1. Home
  2. LGVN vs AEHL Comparison

LGVN vs AEHL Comparison

Compare LGVN & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • AEHL
  • Stock Information
  • Founded
  • LGVN 2014
  • AEHL 1993
  • Country
  • LGVN United States
  • AEHL China
  • Employees
  • LGVN N/A
  • AEHL N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • AEHL Building Materials
  • Sector
  • LGVN Health Care
  • AEHL Industrials
  • Exchange
  • LGVN Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • LGVN 17.6M
  • AEHL 17.3M
  • IPO Year
  • LGVN 2021
  • AEHL 2007
  • Fundamental
  • Price
  • LGVN $0.83
  • AEHL $2.13
  • Analyst Decision
  • LGVN Strong Buy
  • AEHL
  • Analyst Count
  • LGVN 2
  • AEHL 0
  • Target Price
  • LGVN $6.50
  • AEHL N/A
  • AVG Volume (30 Days)
  • LGVN 553.9K
  • AEHL 405.9K
  • Earning Date
  • LGVN 11-04-2025
  • AEHL 12-26-2025
  • Dividend Yield
  • LGVN N/A
  • AEHL N/A
  • EPS Growth
  • LGVN N/A
  • AEHL N/A
  • EPS
  • LGVN N/A
  • AEHL N/A
  • Revenue
  • LGVN $2,073,000.00
  • AEHL $98,773,000.00
  • Revenue This Year
  • LGVN N/A
  • AEHL N/A
  • Revenue Next Year
  • LGVN N/A
  • AEHL N/A
  • P/E Ratio
  • LGVN N/A
  • AEHL N/A
  • Revenue Growth
  • LGVN 68.67
  • AEHL 36.99
  • 52 Week Low
  • LGVN $0.63
  • AEHL $1.78
  • 52 Week High
  • LGVN $2.31
  • AEHL $14.66
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 48.16
  • AEHL 35.65
  • Support Level
  • LGVN $0.75
  • AEHL $1.78
  • Resistance Level
  • LGVN $0.85
  • AEHL $3.14
  • Average True Range (ATR)
  • LGVN 0.05
  • AEHL 0.46
  • MACD
  • LGVN 0.01
  • AEHL -0.16
  • Stochastic Oscillator
  • LGVN 44.30
  • AEHL 13.56

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

Share on Social Networks: